JEREMY BOOTY: Open Payments
NPI 1669877189 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 26 payments from 9 companies in 2025. Trend: 2023 $431 · 2024 $617 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $180 |
| E.R. Squibb & Sons, L.L.C. | 2 | $95 |
| Neurocrine BioSciences, Inc. | 2 | $69 |
| Exact Sciences Corporation | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Lilly USA, LLC | 1 | $30 |
| Corium, LLC | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, COBENFY, INGREZZA, The Cologuard Plus Collection Kit, FANAPT, MOUNJARO, Azstarys, TRELEGY ELLIPTA.
Industry payments across CT — which companies pay providers there.
